- This event has passed.
2023 BioNJ C-Suite Summit
October 6, 2023 @ 7:30 am – 4:00 pm
Registration for the C-Suite Summit is closed. Please contact BioNJ Headquarters at 609-890-3185 with any questions or to be added to a wait list.
Chasing Breakthrough Innovation in a Time of Uncertainty
With Insights from McKinsey & Company
Friday, October 6, 2023 • 7:30 a.m.-4:00 p.m.
Bridgewater Marriott, 700 Commons Way, Bridgewater
We are facing a period of discontinuous change marked by the ever-accelerating AI revolution and advancements in therapeutics ― set against the backdrop of increasing lifecycle compression (exacerbated by the Inflation Reduction Act), a tumultuous fundraising environment, and growing macroeconomic uncertainty.
Join BioNJ and industry leaders on October 6 to explore the implications of these evolutions, with a focus on the trajectory of breakthrough innovation. In addition to timely topics, such as a futuristic look at innovation, reimagining the biopharma workforce and the transformative impact of technology and AI on the industry, be on hand for these Keynotes…
| Time | Take a look at the agenda... |
|---|---|
7:30 a.m. – 8:15 a.m. | Registration & Networking Breakfast |
8:15 a.m. – 8:30 a.m. | Welcome & Opening Remarks
  |
8:30 a.m. – 9:00 a.m.
| Keynote: Creating Breakthroughs Biopharma has been on the forefront of innovation and investment for our industry, delivering 500+ therapies, ~$1T+ in acquisitions and ~1T+ in total shareholder value over the last 20 years. As investment in biopharma plateaus, questions are being raised about the future of innovation for our industry. Join us in reflecting on what the future of innovation for biopharma and beyond may look like, including new commercialization models and how portfolios are prioritized and asset development is accelerated.
 |
9:00 a.m. – 9:45 a.m.
| Panel: State of the Industry Industry leaders will reflect on learnings, priorities and expected evolutions across most pressing topics for the industry, including fundraising challenges, advancements in clinical innovation, the trajectory of policy reforms, the adoption and impact of ESG priorities, talent attraction and retention strategies and the state of technology breakthroughs.
Expert Panelists:
Conversation Leader:
      |
9:45 a.m. – 10:15 a.m.
| Fireside Chat: The Pace of Innovation Many life sciences companies are reassessing their pipeline and portfolio strategies in light of recent policy changes and upcoming blockbuster patent expiries. This talk will explore innovation in the industry and strategic choices companies are evaluating in light of implications for the future trajectory of innovation. Featured Guest:
  |
10:15 a.m. – 10:45 a.m. | Networking Break |
10:45 a.m. – 11:30 a.m.
| Panel: The Next Horizon of Therapeutic Innovation and Patient and Industry Impact New technologies are proliferating – from continued exploration in cell and gene therapy to the rise of mRNA-based platform technologies. As these therapies grow, the bar rises in terms of safety, efficacy and Patient convenience / Patient support. This talk will explore key enablers of success for innovative therapeutics in development and reimbursement, and broader implications for evolutions in the industry.
Expert Panelists:
     |
11:30 a.m. – 12:00 p.m.
| A Fireside Chat: Evolving Capital Markets The life sciences industry market cap has more than tripled in a decade, with biotechs leading shareholder returns. However, recent macroeconomic, geopolitical and regulatory changes create new challenges. During our discussion, we'll explore the latest funding environment and implications for industry structure and raising capital.
Expert Panelists:
Conversation Leader:
   |
12:00 p.m. – 1:00 p.m. | Networking Lunch |
1:00 p.m. – 1:45 p.m. | Panel: Navigating the Complex Path Ahead for Life Sciences Financing and M&A
The life sciences industry is facing an unprecedented environment to finance innovation, overcoming regulatory uncertainties caused by the IRA and FTC lawsuits, and macro-economic slowdown with high cost of capital. On the other hand, large pharma companies need to replenish their topline by offsetting the losses due to patent expirations of their biologics pipeline. In this complex environment, the panel will discuss how to fund the innovation.
Expert Panelists:
Conversation Leader:
     |
1:45 p.m. – 2:30 p.m. | Panel: Talent Management in Biopharma In light of ongoing market shifts, the life sciences industry must proactively invest to shape its talent strategy of the future. This talk will explore key priorities ranging from top-talent attraction and retention with a focus on diversity, equity and inclusion to upskilling and re-skilling parts of the workforce as well as continuing to navigate a hybrid working model.
Expert Panelists:
     |
2:30 p.m. – 3:15 p.m. | Panel: The Transformative Impact of Digital / AI in Biopharma AI has begun to transform biopharma companies, from clinical development to commercial models. The next few years will likely be characterized by continued acceleration in adoption. This talk will explore potential sources of disruption and key opportunities for life sciences companies of all stages.
Expert Panelists:
    |
3:15 p.m. – 3:30 p.m.
| Closing Remarks |
3:30 p.m. – 4:00 p.m.
| Networking Reception |
Click here to register. Registration is $695 for BioNJ Members and $895 for future BioNJ Members. BioNJ’s C-Suite Summit brings together more than 200 life sciences executives ― representing a wide breadth of companies from early to late-stage, public and private and revenue and pre-revenue ― for networking and timely discussions on what’s impacting C-Suite decision-making in bringing new innovation to market.
Sponsorship opportunities are now available. Contact Cheri Hennessy at CHennessy@BioNJ.org to learn more.
